_1991 to 1998 – From raw-materials broker to a service provider for drug marketing authorisation

Pharma Resources was founded in 1991 by the merchant Peter Franck in Ahrensburg, near Hamburg. At the time of its foundation, the sole business activity performed by Pharma Resources was the trade in pharmaceutical raw materials. In the following years the company established services for marketing authorisations as additional line of business under the Management of Dr. Gabriele Schluttig as a supplement to dealing with raw materials. The business developed successfully; nevertheless, in 1998, Peter Franck decided for personal reasons to sell his company to the Swiss-based Dolder AG.

_2002 to 2010 – In the hands of two experts back in Germany

After Switzerland proved to be a disadvantageous location for the service business with marketing authorisations, Pharma Resources was taken over in a management buy out (already four years after the takeover by the Dolder AG) by the two executives Dr. Gabriele Schluttig and Hermann Kopf. The company's main office was relocated once again to Germany, this time to Dreieich near Frankfurt am Main. As of 2002, with several interesting development projects,  Pharma Resources succeeded in gaining renowned customers for the service business and laying a broad cornerstone for the company's success in the years that followed.

• Informationsbeauftragter § 74 a AMG 
• Examination of compliance for markings, PIL, SmPC with the marketing authorisation contents and the registration.
• Control and release of primary/secondary packaging material
• Control and release of the SmPC
• Compilation and treatment of expert certificates to the clinic and pharmacology toxicology part within the scope of marketing authorisation procedure and development projects.

We know that products, which are already established on the market, also require long-term and specialised maintenance – and we will take care of this for you! We will perform the entire scope of pharmacovigilance measures for your drugs, assume the responsibility for drug safety and upon request we provide the Stufenplanbeauftragten – or the "Qualified Person for Pharmacovigilance".

We offer our customers various dossiers and marketing authorisations and/or doublet marketing authorisations for different pharmaceutical forms. We advise the particularly hurried among our customers that some of these drugs are still under patent protection and may only be sold following the expiration of the patent protection!

A licence on a national marketing authorisation can also be very interesting for export markets and puts a favorable possibility to open new markets.

On the right side you find our actual marketing authorisations:

To have your drug procured via our channels saves not merely resources and time, but also hard cash!

Since we simultaneously take care of the supply with marketing authorisations-compliant products during the organisational establishment of development projects with contract manufacturers for chemically- defined and biotechnological drugs for several customers at a time, we can pass the attained cost effect on to you.

Simply use our Know How. 

We will take over the role of a moderator and give you support during the negotiation and organisation up to the signing of the contract. In this case contracts will come to an end very easy.

We know: Success has many fathers – yet indeed, from nothing, nothing comes! This is why we perform our work for our customers with dedication and passion.

_Courage opens doors to the future.

Whoever seeks to create something new must part ways with that which is familiar. Even when changes are sometimes unsettling, we venture to break new ground day after day. In co-operation with you, we apply our courage and our team's abandon in order to always be one step ahead of established processes.

_Performance enables our company's success.

Whoever is not just interested in one's own success but is also willing to assume responsibility for customers' success must reliably and constantly perform at the highest possible level. We only promise what we can deliver – and take action rather than talking too extensively about it. After all, we know: Your success depends not on our promises, but on our performance for you!

_Respect establishes partnership-based co-operation.

Whether within our team or in contact with you – in the context of our business relationships, we strive for a spirit of co-operation which in the context of all of our specialised scientific expertise is based on respect for different insights, practises and experiences. This is the only way that we can learn from each other and benefit each other.

_Integrity ensures our credibility.

Only someone who takes action day by day in keeping with personal convictions, standards and moral concepts can be true to oneself and a reliable and at any time credible partner to a counterpart. That's why in our dealings with you, we do not float with the tide – rather, we are who we are – today, tomorrow and likewise the day after tomorrow.

• DexaMedica / Ferron – Indonesia
• Heumann - Germany
• Thymoorgan - Germany
• Pioneer / Sanvin - India
• Hexal - Germany
• Xellex - Sitzerland
• Haupt Pharma - Germany

_ Bundesverband der Arzneihersteller e.V. (BAH – German Federal Drug Manufacturers' Association, a registered association).
As a member of the BAH, we are connected to an interesting network which not only offers us contact to other member companies, but also – beyond that several possibilities to provide continuing education to our team of experts.

_Deutsche Gesellschaft für Regulatory Affairs.
The membership in the Deutsche Gesellschaft für Regulatory Affairs enables us to always maintain our knowledge base on regulatory and medical affairs at the "state of the art" level. Not at least by the way of the constant training and continuing education of our young employees up to the level "Master of Regulatory Affairs“ in the adjacent Academy operated by the company.